Showing 1 - 4 results of 4 for search 'Tom Degenhardt', query time: 0.03s Refine Results
  1. 1
    Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2− Early Breast Cancer

    Molecular Prognostic Factors for Distant Metastases in Premenopausal Patients with HR+/HER2− Early Breast Cancer by Hua Ni, Jörg Kumbrink, Doris Mayr, Alina Seiler, Friederike Hagemann, Tom Degenhardt, Sabine Sagebiel, Rachel Würstlein, Ronald Kates, Nadia Harbeck, Tanja K. Eggersmann

    Published 2021-08-01
    Get full text
    Article
  2. 2
    First Evidence for a Role of Siglec-8 in Breast Cancer

    First Evidence for a Role of Siglec-8 in Breast Cancer by Anna Trebo, Nina Ditsch, Tom Degenhardt, Christina Kuhn, Martina Rahmeh, Elisa Schmoeckel, Doris Mayr, Bastian Czogalla, Thomas Kolben, Sarah Meister, Sven Mahner, Udo Jeschke, Anna Hester

    Published 2021-02-01
    Get full text
    Article
  3. 3
    ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study

    ERANET JTC 2011: Submission and Activation of an International Academic Translational Project in Advanced Breast Cancer. Experience From the ET-FES Study by Manuela Monti, Tom Degenhardt, Etienne Brain, Rachel Wuerstlein, Alessandra Argusti, Matteo Puntoni, Gian Andrea Rollandi, Davide Corradengo, Luca Boni, Harun Ilhan, Oriana Nanni, Javier Cortes, Alejandro Piris-Gimenez, Arnoldo Piccardo, Massimiliano Iacozzi, Federica Matteucci, Valentina Di Iorio, Jean Louis Alberini, Carolien Schröder, Nadia Harbeck, Alessandra Gennari

    Published 2022-01-01
    Get full text
    Article
  4. 4
    PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with hormone receptor positive, HER2 negative locally advanced or metastatic breast cancer treated with palbociclib and an aromatase inhibitor or palbociclib and fulvestrant

    PRECYCLE: multicenter, randomized phase IV intergroup trial to evaluate the impact of eHealth-based patient-reported outcome (PRO) assessment on quality of life in patients with ho... by Tom Degenhardt, Peter A. Fasching, Diana Lüftner, Volkmar Müller, Christoph Thomssen, Christian Schem, Isabell Witzel, Thomas Decker, Hans Tesch, Sherko Kümmel, Christoph Uleer, Rachel Wuerstlein, Oliver Hoffmann, Mathias Warm, Norbert Marschner, Timo Schinköthe, Ronald E. Kates, Johannes Schumacher, Burkhard Otremba, Matthias Zaiss, Nadia Harbeck, Marcus Schmidt, on behalf of the PreCycle Investigators

    Published 2023-05-01
    Get full text
    Article

Search Tools: